TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12052850

Group type: EXPERIMENTAL
Intervention: Cigarette smoking
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine (TDN)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nasal nicotine spray (NNS)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo NNS
Number of subjects: 12
Study: 10385777

Group type: EXPERIMENTAL
Intervention: 125 mg aspirin daily (group A1)
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: 125 mg aspirin on alternate days (group A2)
Number of subjects: 285

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 285
Study: 7759653

Group type: EXPERIMENTAL
Intervention: Coherent frequency modulation (FM) at a rate of 6 Hz and modulation depth of +/‐ 5%.
Number of subjects: 4

Group type: COMPARATOR
Intervention: No frequency modulation (FM).
Number of subjects: 4
Study: 2370089

Group type: EXPERIMENTAL
Intervention: Product of protein/creatinine ratio and estimated daily urinary creatinine excretion
Number of subjects: 40
Study: 93179

Group type: EXPERIMENTAL
Intervention: End-to-side jejunoileostomy (bypass)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Non-surgical treatment (control)
Number of subjects: 196
Study: 30636726

Group type: EXPERIMENTAL
Intervention: Stretching protocol (group A)
Number of subjects: 18

Group type: COMPARATOR
Intervention: No-stretching (group B)
Number of subjects: 18
Study: 27131792

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 176
Study: 26030032

Group type: EXPERIMENTAL
Intervention: Clonidine-based hypotensive anaesthesia
Number of subjects: 47

Group type: COMPARATOR
Intervention: Remifentanil-based hypotensive anaesthesia
Number of subjects: 47
Study: 23999452

Group type: EXPERIMENTAL
Intervention: Basal insulin glargine titrated to a fasting glucose of ≤ 5.3 mmol/L (95 mg/dL)
Number of subjects: 12537

Group type: COMPARATOR
Intervention: Standard glycaemic care
Number of subjects: 12537

Group type: EXPERIMENTAL
Intervention: Severe hypoglycaemia
Number of subjects: 12537

Group type: EXPERIMENTAL
Intervention: Severe nocturnal hypoglycaemia
Number of subjects: 12537

Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 12537
Study: 21895365

Group type: EXPERIMENTAL
Intervention: Comprehension of referential pointing at 9 months
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Comprehension of an imperative motive at 12 months
Number of subjects: 88
Study: 18810661

Group type: EXPERIMENTAL
Intervention: Tirilazad
Number of subjects: 3797
Study: 16781788

Group type: EXPERIMENTAL
Intervention: Omacor (1 g/day)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 35
Study: 15347469

Group type: EXPERIMENTAL
Intervention: Fluoxetine plus HRT
Number of subjects: 54

Group type: COMPARATOR
Intervention: HRT
Number of subjects: 54
Study: 11479779

Group type: EXPERIMENTAL
Intervention: Bryonia in a 12c potency
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 9754466

Group type: EXPERIMENTAL
Intervention: Dialysis solution containing 2.5% glucose
Number of subjects: 32

Group type: COMPARATOR
Intervention: Dialysis solution containing 1.5% glucose
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: CAPD
Number of subjects: 32
Study: 8311013

Group type: EXPERIMENTAL
Intervention: Chemotherapy (CT: cisplatin 50 mg/m2 + cyclophosphamide 600 mg/m2 day 1 every 28 days for 6 courses)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Whole abdominal radiotherapy (WAR: 43.2 Gy/24 fractions to the pelvis and 30.2 Gy to the upper abdomen)
Number of subjects: 70
Study: 3392234

Group type: EXPERIMENTAL
Intervention: Doryx (enteric-coated doxycycline hyclate pellets)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Vibramycin (doxycycline hyclate powder)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study: 30336702

Group type: EXPERIMENTAL
Intervention: Prolonged exposure
Number of subjects: 200

Group type: COMPARATOR
Intervention: Sertraline
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Preferred treatment (either Prolonged exposure or Sertraline)
Number of subjects: 200
Study: 28211344

Group type: EXPERIMENTAL
Intervention: Egg white recipe validated in phase 1 (n=89 volunteers)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Milk recipe validated in phase 2 (n=30 participants)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Hazelnut recipe validated in phase 2 (n=30 participants)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Visual Analog Scale (VAS) scores for the 3 recipes
Number of subjects: 197
Study: 26701606

Group type: EXPERIMENTAL
Intervention: α-mangostin nanoparticles applied twice daily for 4 weeks
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 10
Study: 23294853

Group type: EXPERIMENTAL
Intervention: 2-weekly docetaxel (50 mg/m² on days 1 and 15 of a 4-week cycle)
Number of subjects: 361

Group type: COMPARATOR
Intervention: 3-weekly docetaxel (75 mg/m² on day 1 of a 3-week cycle)
Number of subjects: 361

Group type: COMPARATOR
Intervention: 3-weekly docetaxel
Number of subjects: 361
Study: 21511218

Group type: EXPERIMENTAL
Intervention: 300 mg clopidogrel loading dose (LD)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: 900 mg clopidogrel loading dose (LD)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Both 300 mg and 900 mg clopidogrel loading doses
Number of subjects: 109
Study: 18383517

Group type: EXPERIMENTAL
Intervention: Antiandrogen withdrawal
Number of subjects: 210
Study: 16595223

Group type: EXPERIMENTAL
Intervention: Drospirenone 3 mg and ethinyl estradiol 30 microg for 12 cycles
Number of subjects: 50
Study: 12904635

Group type: EXPERIMENTAL
Intervention: T50 (50% reduction in training volume)
Number of subjects: 11

Group type: COMPARATOR
Intervention: T30 (30% reduction in training volume)
Number of subjects: 11

Group type: COMPARATOR
Intervention: T80 (80% reduction in training volume)
Number of subjects: 11
Study: 10834865

Group type: EXPERIMENTAL
Intervention: Potent SAARD with a short lag time (methotrexate, if necessary replaced by sulfasalazine)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Potent SAARD with a long lag time (intramuscular gold, if necessary replaced by D-penicillamine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mild SAARD with a long lag time (hydroxychloroquine, if necessary replaced by auranofin)
Number of subjects: 0
Study: 9113250

Group type: EXPERIMENTAL
Intervention: 100-proof vodka (1.5 ml/kg) in orange juice
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 8458059

Group type: EXPERIMENTAL
Intervention: 37.5 mg/hr cimetidine
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 50 mg/hr cimetidine
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 3462467

Group type: COMPARATOR
Intervention: Vincristine and Prednisone (VP)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Vincristine, Prednisone, and Anthracycline (VPA)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Vincristine and Prednisone (VP) for boys
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Vincristine, Prednisone, and Anthracycline (VPA) for boys
Number of subjects: 137
Study: 30587220

Group type: EXPERIMENTAL
Intervention: Discussion with sexual partner
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: Discussion with peers
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: Not co-residing with both parents
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: Positive self-perception of HIV risk
Number of subjects: 648
Study: 26809009

Group type: EXPERIMENTAL
Intervention: Knee osteoarthritis subjects
Number of subjects: 46

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 46
Study: 25604307

Group type: EXPERIMENTAL
Intervention: MI-CHE
Number of subjects: 40

Group type: COMPARATOR
Intervention: CLC
Number of subjects: 40
Study: 23083841

Group type: EXPERIMENTAL
Intervention: Baseline CRP
Number of subjects: 1049

Group type: EXPERIMENTAL
Intervention: Change in CRP (standardised to 1SD) during follow-up
Number of subjects: 1049
Study: 19486488

Group type: COMPARATOR
Intervention: Concentric reinforcement (CG)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Eccentric reinforcement (EG)
Number of subjects: 18
Study: 18973097

Group type: EXPERIMENTAL
Intervention: Desloratadine plus montelukast
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Montelukast plus levocetirizine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 16049637

Group type: EXPERIMENTAL
Intervention: Rivastigmine (mean dose 8.6 +/- 1.3 mg) for 12 months
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Rivastigmine (mean dose 10.5-12 mg) for 12 months
Number of subjects: 11

Group type: COMPARATOR
Intervention: Untreated group of 10 AD patients
Number of subjects: 11
Study: 14597933

Group type: EXPERIMENTAL
Intervention: GUSTO trial
Number of subjects: 3

Group type: COMPARATOR
Intervention: NRMI
Number of subjects: 3

Group type: COMPARATOR
Intervention: CCP
Number of subjects: 3
Study: 11205684

Group type: EXPERIMENTAL
Intervention: Non-classical trial designs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Classical clinical trial designs
Number of subjects: 0
Study: 8726592

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sulfonylurea (maximum dosages)
Number of subjects: 0
Study: 1457622

Group type: EXPERIMENTAL
Intervention: 100 mg denbufylline BID
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 6326784

Group type: EXPERIMENTAL
Intervention: Intravenous prenalterol (5 mg)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Sustained oral prenalterol (100 mg twice a day)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo (during oral crossover study)
Number of subjects: 7
Study: 30983953

Group type: EXPERIMENTAL
Intervention: HAL-BWSTT
Number of subjects: 18

Group type: COMPARATOR
Intervention: CPT
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both therapies (HAL-BWSTT and CPT)
Number of subjects: 18
Study: 27739626

Group type: EXPERIMENTAL
Intervention: Minimal psychosocial intervention
Number of subjects: 314

Group type: COMPARATOR
Intervention: Usual GP care
Number of subjects: 314
Study: 26266401

Group type: EXPERIMENTAL
Intervention: Combination therapy (IPL + NIR + fractional Er:YAG laser)
Number of subjects: 113

Group type: COMPARATOR
Intervention: IPL monotherapy
Number of subjects: 113
Study: 25293442

Group type: EXPERIMENTAL
Intervention: Lifestyle weight loss group (LWL)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 30
Study: 21703942

Group type: EXPERIMENTAL
Intervention: Potassium calcium citrate (PCC)
Number of subjects: 24
Study: 19231488

Group type: EXPERIMENTAL
Intervention: Precut procedure performed immediately after randomization (Group A)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Standard cannulation attempts followed by needle-knife precut if necessary (Group B)
Number of subjects: 146
Study: 17468667

Group type: EXPERIMENTAL
Intervention: Immediate Switch (IS) arm
Number of subjects: 147

Group type: COMPARATOR
Intervention: Structured Treatment Interruption (STI) arm
Number of subjects: 147

Group type: COMPARATOR
Intervention: STI arm
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Both arms
Number of subjects: 147
Study: 15458587

Group type: EXPERIMENTAL
Intervention: Left and bilateral infarctions
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Left infarctions
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Severity of SAH
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Modified Rankin scale
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Cognitive tests
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Questionnaire ratings of mental impairments
Number of subjects: 170
Study: 15978307

Group type: EXPERIMENTAL
Intervention: Flurbiprofen axetil 50 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Flurbiprofen axetil 75 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Flurbiprofen axetil 25 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (vehicle)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Flurbiprofen axetil 50 mg vs 25 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Flurbiprofen axetil 75 mg vs 25 mg
Number of subjects: 120
Study: 10481502

Group type: EXPERIMENTAL
Intervention: Musicians (DPOAE measurements)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Absolute pitch possessors (APP)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Relative pitch possessors (RPP)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Non-musicians (Control group)
Number of subjects: 82
Study: 8752873

Group type: EXPERIMENTAL
Intervention: Combined transbasal & transfacial approach (Type A)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Combined transbasal & transfacial approach (Type B)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Combined transbasal & transfacial approach (Type C)
Number of subjects: 19
Study: 1842010

Group type: EXPERIMENTAL
Intervention: Tipi tea
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo tea (Imperata exaltata - sape)
Number of subjects: 14
Study: 6277020

Group type: EXPERIMENTAL
Intervention: Guar-containing biscuit; specific dosage and duration not mentioned.
Number of subjects: 0
Study: 30633181

Group type: EXPERIMENTAL
Intervention: Pelvis reposition exercise (15-minute trial)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study: 30282142

Group type: EXPERIMENTAL
Intervention: Water caloric test
Number of subjects: 60

Group type: COMPARATOR
Intervention: Air caloric test
Number of subjects: 60
Study: 27784733

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 2993

Group type: EXPERIMENTAL
Intervention: Metformin treatment
Number of subjects: 2993

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 2993
Study: 24571932

Group type: EXPERIMENTAL
Intervention: Mini booster (telephone MI sessions)
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Full booster (face to face MI sessions)
Number of subjects: 282

Group type: COMPARATOR
Intervention: Control (no further intervention)
Number of subjects: 282
Study: 22910336

Group type: EXPERIMENTAL
Intervention: Intracutaneous stitches
Number of subjects: 124

Group type: COMPARATOR
Intervention: Staples
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Closure of the fat layer
Number of subjects: 124

Group type: COMPARATOR
Intervention: No closure of the fat layer
Number of subjects: 124
Study: 20701514

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (CC) 100 mg with FSH
Number of subjects: 280

Group type: COMPARATOR
Intervention: Letrozole 5 mg daily with FSH
Number of subjects: 280

Group type: COMPARATOR
Intervention: Letrozole group
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate group
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 280
Study: 17414743

Group type: EXPERIMENTAL
Intervention: Duloxetine 60‐120 mg/day
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: Venlafaxine XR 75‐225 mg/day
Number of subjects: 487

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 487
Study: 16288616

Group type: EXPERIMENTAL
Intervention: Capsaicin ointment
Number of subjects: 186

Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 186
Study: 14606379

Group type: EXPERIMENTAL
Intervention: Sevoflurane terminated 30 minutes before awakening (Group A)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sevoflurane terminated 10 minutes before awakening (Group B)
Number of subjects: 80
Study: 10188750

Group type: EXPERIMENTAL
Intervention: Push-up (PU)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Bench press-load (BP-L)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Bench press-no load (BP-NL)
Number of subjects: 10
Study: 7797058

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspirin desensitization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New anti-inflammatory agents (methotrexate, hydroxychloroquine, auronifin, sulfonylureas)
Number of subjects: 0
Study: 30782354

Group type: EXPERIMENTAL
Intervention: Self-reported medication nonadherence measure
Number of subjects: 236
Study: 28976437

Group type: EXPERIMENTAL
Intervention: IKACTA tool
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (no additional learning material)
Number of subjects: 16
Study: 25799447

Group type: EXPERIMENTAL
Intervention: G1 Clearfil SE Bond/Filtek Z350
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: G2 Adper Easy One/Filtek Z350
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: G3 P90 Adhesive System/Filtek P90
Number of subjects: 27
Study: 23639375

Group type: EXPERIMENTAL
Intervention: Active TENS (120 Hz/low-intensity) applied homotopically, over the left common peroneal nerve
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham TENS (2 Hz/low-intensity) positioned heterotopically, over the left thigh
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham TENS (replication of condition T1)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Active TENS (120 Hz/low-intensity)
Number of subjects: 20
Study: 21284838

Group type: EXPERIMENTAL
Intervention: Brief tailored psychosocial intervention delivered by trained health professionals, up to 4 sessions of 30 minutes each, face-to-face or by telephone.
Number of subjects: 600

Group type: COMPARATOR
Intervention: Control condition (not specified in detail).
Number of subjects: 600
Study: 18035191

Group type: EXPERIMENTAL
Intervention: Travoprost 0.004%
Number of subjects: 302

Group type: COMPARATOR
Intervention: Latanoprost 0.005%
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Travoprost 0.004% (open-label phase)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Latanoprost 0.005% switched to Travoprost 0.004% (open-label phase)
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Ocular adverse events (AEs) with Travoprost
Number of subjects: 302

Group type: COMPARATOR
Intervention: Ocular adverse events (AEs) with Latanoprost
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Ocular adverse events (AEs) with Open-label Travoprost
Number of subjects: 302
Study: 16030053

Group type: EXPERIMENTAL
Intervention: Cinacalcet (initiated at 30 mg, escalated to a maximum of 180 mg once daily)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Cinacalcet (30 mg to 180 mg once daily)
Number of subjects: 59
Study: 11799484

Group type: EXPERIMENTAL
Intervention: TAC, prednisone, and MMF therapy (group T)
Number of subjects: 106

Group type: COMPARATOR
Intervention: TAC and prednisone therapy (group D)
Number of subjects: 106
Study: 10618943

Group type: COMPARATOR
Intervention: Non-dominant hand tactile assessment using TOF
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-dominant hand tactile assessment using DBS3,3
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-dominant hand tactile assessment using DBS3,2
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-dominant hand tactile assessment of ulnar nerve stimulation
Number of subjects: 0
Study: 8955458

Group type: EXPERIMENTAL
Intervention: Symptomatic ventricular septal defect (VSD) group
Number of subjects: 26

Group type: COMPARATOR
Intervention: Healthy infants (control group)
Number of subjects: 26
Study: 1658281

Group type: EXPERIMENTAL
Intervention: Fiber-supplemented formula (Isomil plus soy polysaccharide)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo (Isomil formula)
Number of subjects: 27
Study: 6181324

Group type: EXPERIMENTAL
Intervention: BHT-933 5 mg
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 31755968

Group type: EXPERIMENTAL
Intervention: Intravitreal ziv-aflibercept 1.25 mg
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Bevacizumab (IVB)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Intravitreal ziv-aflibercept 2.5 mg
Number of subjects: 123
Study: 30172362

Group type: EXPERIMENTAL
Intervention: JVD only
Number of subjects: 7135

Group type: EXPERIMENTAL
Intervention: Peripheral edema only
Number of subjects: 7135

Group type: EXPERIMENTAL
Intervention: JVD and peripheral edema
Number of subjects: 7135

Group type: COMPARATOR
Intervention: No JVD or peripheral edema
Number of subjects: 7135

Group type: EXPERIMENTAL
Intervention: All groups (1-4)
Number of subjects: 7135
Study: 27544361

Group type: EXPERIMENTAL
Intervention: Rectal indomethacin (100mg)
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: Intravenous saline perfusion
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: Rectal indomethacin (100mg) and IV saline
Number of subjects: 406

Group type: COMPARATOR
Intervention: Rectal glycerin (control)
Number of subjects: 406
Study: 25161823

Group type: EXPERIMENTAL
Intervention: Biofeedback training (BFT) task, performed every day for about 5 min once a day.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Biofeedback training (BFT) task.
Number of subjects: 0
Study: 22089961

Group type: EXPERIMENTAL
Intervention: Polypropylene ankle-foot orthoses
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Silicone ankle-foot orthoses
Number of subjects: 8

Group type: COMPARATOR
Intervention: No orthosis
Number of subjects: 8
Study: 19293589

Group type: EXPERIMENTAL
Intervention: LEC2 (loop electrosurgical conization in two blocks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LEC2
Number of subjects: 0
Study: 19223675

Group type: EXPERIMENTAL
Intervention: Vitamin C supplementation (3x500 mg tablets per day for 12 days)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo supplementation
Number of subjects: 12
Study: 15649728

Group type: EXPERIMENTAL
Intervention: 5000 IU dalteparin injections once daily for 3 months
Number of subjects: 284

Group type: COMPARATOR
Intervention: Placebo injections once daily for 3 months
Number of subjects: 284
Study: 12392217

Group type: EXPERIMENTAL
Intervention: Children's Aid Society-Carrera program
Number of subjects: 600

Group type: COMPARATOR
Intervention: Control group (usual youth program)
Number of subjects: 600
Study: 10436143

Group type: EXPERIMENTAL
Intervention: Argatroban infusion therapy (continuous intravenous infusion for 60 minutes, repeated daily for 2 weeks)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Argatroban infusion therapy
Number of subjects: 10